Clinical Effects of Glucagon-Like Peptide-1 Agonist Use for Weight Loss in Women With Polycystic Ovary Syndrome: A Scoping Review

August 2024 in “ Cureus ”

Melissa Frangie Machado, Taylor Shunk, Grace Hansen, Charles Harvey, Baylee Fulford, Shane Hauf, Olivia Schuh, Matthew Kaldas, Elena Arcaroli, Justin Ortiz, Joseph De Gaetano

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on assets.cureus.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Polycystic Ovary Syndrome (PCOS): An Inflammatory, Systemic, Lifestyle Endocrinopathy

317 citations , April 2018 in “Journal of steroid biochemistry and molecular biology/The Journal of steroid biochemistry and molecular biology”

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

research Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline

1265 citations , October 2013 in “The Journal of Clinical Endocrinology and Metabolism”

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.